TP53 and adenocarcinoma: Furthermore, we reported that high p53 immunostaining correlated with lower tumor differentiation when analyzing the entire NSCLC cohort; however, when we analyzed the adenocarcinoma and squamous cell carcinoma patient subsets independently, we observed that this correlation between p53 and tumor differentiation was only maintained in squamous cell carcinoma.